feedback

Course Director

Jorge E. Cortes, MD
Jorge E. Cortes, MD

The University of Texas MD Anderson Cancer Center
Houston, Texas

Faculty

Stephen A. Strickland
Stephen A. Strickland, MD, MSCI

Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee

Accredited by

The Medical College of Wisconsin

Activity Details

Credit Types:CME
Credit Amount:1.0 Credits
Release Date:2018-Apr-04
Expiration Date:2019-Apr-03
Estimated Time for Completion:60 mintues
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

In this activity, experts in acute myeloid leukemia (AML) guide you through the science that supports the rapid integration of newer induction regimens into the care of AML patients who are eligible for hematopoietic stem cell transplantation (HCT), while offering expert thoughts on what a more diverse selection of induction options means for patients who have the greatest need for alternative treatments, including those with high-risk disease, older individuals who are fit for intensive therapy, or patients with molecular aberrations/mutations conferring a poor prognosis.

Upon completion of this activity, participants should be better able to:

  • Summarize the current role and challenges of HCT and induction therapy in AML, including in elderly and high-risk patients
  • Describe new evidence on novel induction strategies in AML such as novel cytotoxic or targeted strategies
  • Select personalized, safe induction strategies for transplant eligible patients with AML who may not benefit from induction with standard 7+3

Target Audience

This activity has been designed to meet the educational needs of hematologist-oncologists, oncologists, bone marrow transplant (BMT) specialists, BMT nurse specialists, and other clinicians involved in the management of patients with AML.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: April 04, 2018 - April 03, 2019
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, The Medical College of Wisconsin has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Jorge E. Cortes, MD
Jane and John Justin Distinguished Chair in Leukemia Research
Chief, CML & AML Sections
Deputy Chair, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Jorge E. Cortes, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Astellas Pharma US, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Grant/Research Support from Astellas Pharma US, Inc.; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Faculty

Stephen A. Strickland, MD, MSCI
Hematology Clinical Service Line Chief
Clinical Director, Acute Leukemia
Division of Hematology/Oncology
Assistant Professor of Medicine
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee

Stephen A. Strickland, MD, MSCI, has a financial interest/relationship or affiliation in the form of:
Consultant for Pfizer, Inc.
Advisory Board for Novartis Pharmaceuticals Corporation and Pfizer, Inc.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

The Medical College of Wisconsin (MCW) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MCW for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical College of Wisconsin and PVI, PeerView Institute for Medical Education. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

The Medical College of Wisconsin designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:

The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Providership

This CME activity is jointly provided by The Medical College of Wisconsin and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME Activity

PVI, PeerView Institute for Medical Education, and The Medical College of Wisconsin are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and The Medical College of Wisconsin.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.